Tricida (TCDA) Tops Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. INTC
6. META
7. JBLU
8. ANT
9. NVDA
10. AAPL

Go back to Tricida (TCDA) Tops Q4 EPS by 4c

Tricida Announces Fourth Quarter and Full-Year 2019 Financial Results

February 27, 2020 4:05 PM EST

Webcast Today at 4:30 pm Eastern Time

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today financial results for the fourth quarter and full-year ended December 31, 2019 and provided an update on key initiatives.

2019 Highlights

The U.S. Food and Drug Administration (FDA) accepted for review, through the... More